1. Peter Reynolds Peter Reynolds United Kingdom says:

    This 'investigative journalism' seems to have a massive blind spot. The entire medical establishment and pharma industry has been engaged in identical conflicts of interest for the past 100 years. Nothing new here at all.

    There is great concern about the bullying, monopolistic ambitions, media manipulation, misrepresentation of research and false claims coming from the Paul Birch/Steve Moore faction. but exactly the same is going on with the BPNA.  It has published paediatric guidelines for medicinal cannabis which effectively prevent its use without clinical trials while its director, Dr Finbar O'Callaghan, makes his living from running such trials.  Similarly, Marta Di Forti and the Institute of Psychiatry, Psychology and Neuroscience at King’s College London, are ebngaged in systematic 'research campaigning' against the use of cannabis based on the funding they have received for many years and which keeps them in work running repetitive and highgly questionable studies.

    Millions of people gain great benefit from  cannabis, most of whom access it illegally.  The vested interests working against it and desperate to prevent its legalisation and wider use have the same ulterior motives as the cananbsi industry - cash and profit.

    What really terrifies the medical establishment and industry is that cannabis is so very safe for most people that growing your own is a reasonable solution for most and that could devastate the OTC medicines market.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.